220 related articles for article (PubMed ID: 11407828)
1. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
[TBL] [Abstract][Full Text] [Related]
2. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
Kam PC; Thompson JF
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
[TBL] [Abstract][Full Text] [Related]
3. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
4. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
[TBL] [Abstract][Full Text] [Related]
6. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
[TBL] [Abstract][Full Text] [Related]
7. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
[TBL] [Abstract][Full Text] [Related]
9. Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Melanoma Res; 2009 Apr; 19(2):106-11. PubMed ID: 19282789
[TBL] [Abstract][Full Text] [Related]
10. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.
Deroose JP; Eggermont AM; van Geel AN; Verhoef C
Curr Opin Oncol; 2011 Mar; 23(2):183-8. PubMed ID: 21150602
[TBL] [Abstract][Full Text] [Related]
12. Use of an automated circuit for isolated limb infusion for malignancy.
Grobmyer SR; Filichia L; Robinson AR; Clark TD; Vaughn K; Copeland EM; Hochwald SN
Eur J Surg Oncol; 2010 Dec; 36(12):1215-9. PubMed ID: 20947288
[TBL] [Abstract][Full Text] [Related]
13. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
[TBL] [Abstract][Full Text] [Related]
14. Does increased experience with isolated limb infusion for advanced limb melanoma influence outcome? A comparison of two treatment periods at a single institution.
Huismans AM; Kroon HM; Kam PC; Thompson JF
Ann Surg Oncol; 2011 Jul; 18(7):1877-83. PubMed ID: 21499810
[TBL] [Abstract][Full Text] [Related]
15. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
[TBL] [Abstract][Full Text] [Related]
16. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
Testori A; Verhoef C; Kroon HM; Pennacchioli E; Faries MB; Eggermont AM; Thompson JF
J Surg Oncol; 2011 Sep; 104(4):397-404. PubMed ID: 21858835
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
[TBL] [Abstract][Full Text] [Related]
19. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Carr M; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Tyler DS; Coventry BJ; Zager JS; Thompson JF
Ann Surg Oncol; 2020 May; 27(5):1420-1429. PubMed ID: 32152775
[TBL] [Abstract][Full Text] [Related]
20. Quality of life outcomes after isolated limb infusion.
McClaine RJ; Giglia JS; Ahmad SA; McCoy SJ; Sussman JJ
Ann Surg Oncol; 2012 May; 19(5):1373-8. PubMed ID: 22302268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]